Wearable OLED-Assisted Photodynamic Cancer Therapy Using Chlorin e6-Loaded Pluronic Nanocapsules as Photosensitizers

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Photodynamic therapy (PDT) is a promising cancer treatment, but clinical use is limited by light source impracticality and photosensitizer instability.
• Conventional PDT methods face challenges in delivering light effectively and ensuring photosensitizer stability for widespread clinical application.

Purpose of the Study:

• To develop a novel and practical PDT approach using wearable organic light-emitting diodes (OLEDs) and chlorin e6 (Ce6)-loaded nanocapsules for enhanced anticancer therapy.
• To optimize Pluronic nanocapsule formulations for efficient drug delivery and light activation in PDT.

Main Methods:

• Synthesis and characterization of chlorin e6 (Ce6)-loaded Pluronic nanocapsules (Ce6/Plu NCs) with varying Pluronic polymers.
• Evaluation of in vitro therapeutic efficacy of Ce6/PP123 NCs and OLED irradiation.
• Assessment of in vivo tumor accumulation, antitumor efficacy, and off-target toxicity of the developed PDT system.

Main Results:

• Optimized Ce6/PP123 NCs (~120 nm) demonstrated superior spectral characteristics and in vitro anticancer efficacy.
• The Ce6/PP123 NCs showed efficient tumor accumulation and significant in vivo antitumor effects upon irradiation with tissue-attachable OLEDs.
• The novel wearable OLED-based PDT system exhibited minimal off-target toxicity, highlighting its safety profile.

Conclusions:

• The combination of Ce6/PP123 nanocapsules and wearable OLEDs presents a promising platform for effective and safe photodynamic cancer therapy.
• This innovative approach overcomes limitations of conventional PDT, offering a flexible, low-thermal, and wearable light source for improved clinical translation.
• The developed system demonstrates significant potential for advancing minimally invasive cancer treatment strategies.